Safety question
Is Phenibut safe?
High risk — avoid casual recreational use. Phenibut scores 1/5. Serious adverse events are documented in the clinical or coroner record. Use is appropriate only for narrowly-indicated medical purposes under specialist supervision.
Safety score
1 / 5
Evidence grade
C
Severe reactions on file
1
Pubmed cites
110
Key facts
- typical dose
- 250–1000 mg
- dose frequency
- max 1-2x/week
- timing
- before stressor
- with food
- optional
- onset
- 120 minutes
- half-life
- 5 hours
- safety score
- 1/5
- evidence grade
- C
- class
- research_chemical
- PubMed citations
- 110
- legal status (US)
- Research-chemical category
- legal status (UK)
- Research-chemical category
- legal status (EU)
- Research-chemical category
- legal status (AU)
- Banned
- restrictions
- US (not a legal supplement); AU; UK PSA 2016
- primary mechanism
- Direct agonist at GABA-B receptors — the same mechanism as the prescription anti-spasticity drug baclofen.
Common side effects
- Severe dependence/withdrawalsevere
- Tolerance within days of regular usemoderate
- Sedationmoderate
Severe reaction risks
Phenibut has the following documented severe adverse reactions: Severe dependence/withdrawal. These are rare but require immediate medical attention if they occur.
Banned or restricted in
- US (not a legal supplement)
- AU
- UK PSA 2016
Restrictions can include outright bans, prescription-only classification, anti-doping prohibitions (WADA), or supplement-marketing restrictions. Check your local regulator before purchasing.
Who should not take Phenibut
- Pregnant or breastfeeding individuals — most nootropics have not been adequately studied in pregnancy, and the precautionary principle applies.
- Anyone on a prescription medication that overlaps mechanistically (stimulants, SSRIs, MAOIs, beta-blockers, anticoagulants) — clear interactions with your prescribing clinician before adding Phenibut.
- Anyone with significant cardiovascular, hepatic, renal, or psychiatric disease — established conditions raise the baseline risk for any new compound.
- Minors — almost no nootropics have a paediatric safety record, and developing brains are differently sensitive.
What "safe" means here
Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.
A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.
Full mechanism, citations, and dose guidance for Phenibut are on the main reference page — see Phenibut. For the dose-by-dose breakdown, see Phenibut dosage. To check stack interactions, use the interaction checker.
This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.